Don Rockey to Liver Diseases
This is a "connection" page, showing publications Don Rockey has written about Liver Diseases.
Connection Strength
11.373
-
Coronavirus disease 2019 and the liver. Curr Opin Gastroenterol. 2022 05 01; 38(3):191-199.
Score: 0.669
-
The Utility of Liver Biopsy in the Evaluation of Liver Disease and Abnormal Liver Function Tests. Am J Clin Pathol. 2021 07 06; 156(2):259-267.
Score: 0.638
-
Letter: Confounders and outcomes in studies of beta-blockers in liver disease-role of PPIs? Authors' reply. Aliment Pharmacol Ther. 2021 07; 54(1):91.
Score: 0.638
-
Reply to Schierwagen et al.: ?-Arrestins in liver disease. Proc Natl Acad Sci U S A. 2020 11 03; 117(44):27085-27086.
Score: 0.609
-
The utility of liver biopsy in 2020. Curr Opin Gastroenterol. 2020 05; 36(3):184-191.
Score: 0.588
-
Editorial: Advances in hepatology - 2020. Curr Opin Gastroenterol. 2020 05; 36(3):155-156.
Score: 0.588
-
Abnormal Liver Enzymes. J Gen Intern Med. 2019 09; 34(9):1676.
Score: 0.562
-
Editorial: Advances in Hepatology: 2019. Curr Opin Gastroenterol. 2019 05; 35(3):135-136.
Score: 0.549
-
When Do Clinicians Follow-up Abnormal Liver Tests in Primary Care? Am J Med Sci. 2019 08; 358(2):127-133.
Score: 0.548
-
Advances in Hepatology: 2018. Curr Opin Gastroenterol. 2018 05; 34(3):121-122.
Score: 0.512
-
Assessing the Burden of Abnormal LFTs and the Role of the Electronic Health Record: A Retrospective Study. Am J Med Sci. 2018 Jun; 355(6):537-543.
Score: 0.504
-
Advances in hepatology. Curr Opin Gastroenterol. 2017 05; 33(3):113-114.
Score: 0.478
-
Continued advances for hepatology in 2015. Curr Opin Gastroenterol. 2016 May; 32(3):141-2.
Score: 0.446
-
Endothelial dysfunction in advanced liver disease. Am J Med Sci. 2015 Jan; 349(1):6-16.
Score: 0.407
-
Game-changing advances in hepatology. Curr Opin Gastroenterol. 2014 May; 30(3):215-6.
Score: 0.388
-
Current opinion in gastroenterology. Editorial. Curr Opin Gastroenterol. 2013 May; 29(3):241-2.
Score: 0.362
-
Liver. Curr Opin Gastroenterol. 2011 May; 27(3):203.
Score: 0.315
-
Complications and outcomes in chronic liver disease. Curr Opin Gastroenterol. 2011 May; 27(3):204-9.
Score: 0.315
-
Endothelin and hepatic wound healing. Pharmacol Res. 2011 Jun; 63(6):512-8.
Score: 0.313
-
Liver biopsy. Hepatology. 2009 Mar; 49(3):1017-44.
Score: 0.271
-
Scott L. Friedman, 59th President, AASLD. Hepatology. 2008 Nov; 48(5):1357-8.
Score: 0.265
-
In pursuit of the "Holy Grail"--stem cells, hepatic injury, fibrogenesis and repair. Hepatology. 2005 Jan; 41(1):16-8.
Score: 0.203
-
Nitric oxide biology and the liver: report of an AASLD research workshop. Hepatology. 2004 Jan; 39(1):250-7.
Score: 0.190
-
Vascular mediators in the injured liver. Hepatology. 2003 Jan; 37(1):4-12.
Score: 0.177
-
?-Arrestin2 is a critical component of the GPCR-eNOS signalosome. Proc Natl Acad Sci U S A. 2020 05 26; 117(21):11483-11492.
Score: 0.147
-
Striking cholestatic liver disease: a distinct manifestation of advanced primary amyloidosis. South Med J. 1999 Feb; 92(2):236-41.
Score: 0.135
-
Associations of Race with Follow-up Patterns After Initial Abnormal Liver Tests in Primary Care. J Gen Intern Med. 2018 10; 33(10):1618-1620.
Score: 0.132
-
Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology. 1998 Feb; 27(2):472-80.
Score: 0.126
-
Diagnosis and evaluation of hyperbilirubinemia. Curr Opin Gastroenterol. 2017 May; 33(3):164-170.
Score: 0.119
-
Acute on chronic liver failure: definitions, treatments and outcomes. Curr Opin Gastroenterol. 2016 May; 32(3):172-81.
Score: 0.111
-
Divergent transforming growth factor-beta signaling in hepatic stellate cells after liver injury: functional effects on ECE-1 regulation. Am J Pathol. 2008 Sep; 173(3):716-27.
Score: 0.066